iCAD Granted U.S. Patent on MRI Image Analysis Solutions

iCAD, Inc. ICAD announces that the United States Patent and Trademark Office recently granted the company Patent Number 7,903,853. This patent covers iCAD's magnetic resonance imaging analysis products for breast and prostate cancer detection, and relates to the speed its image analysis solution pinpoints and marks areas that warrant closer inspection from a radiologist.